Wilson has been very candid about her weight struggles over the years. She's referred to herself as an "emotional eater" with a raging sweet tooth and she's admitted to having plenty of weight ...
In 2025, Wolfson Brands has unveiled an advanced line of Best fat-burning supplements for man designed to align with the evolving needs of modern lifestyles. Today, fat management is far from a ...
Nutrition for pets can be confusing, especially calories. You may be wondering how many calories can my dog eat? Here's how to find out.
My mother told me she was worried that her cat, Katy, needed to lose weight. Privately, I agreed. My sister and I spent the weekend with my parents up at their cabin in the woods. Their cat, Katy, is ...
A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially providing an easier alternative to Ozempic injections.
Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and safety of common weight loss supplements.
Pfizer Inc. acquires Metsera to enter the weight-loss drug market. Click to see PFE's dividend strength, growth prospects, and what this deal means for investors.
A recent docuseries on Netflix, "Fit for TV: The Reality of the Biggest Loser," and new book by obesity researcher Kevin Hall, have sparked conversations about the reality show's weight-loss tactics, ...
Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years. Pharma giants Eli Lilly and Novo Nordisk dominate the ma ...
A new Penn Nursing study suggests that the weight-loss drug tirzepatide may cause fewer side effects like nausea and vomiting than the drug semaglutide. This research, published in Science Advances, ...
There is a growing trend of microdosing with Ozempic and other popular weight loss drugs. People are taking much smaller amounts, or splitting up doses, to save money or cut down on side effects. CBS ...
A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike ...